The FDA Law Blog

APRIL 22, 2024

Houck — Administrator Anne Milgram has been on the receiving end of high-level support for and against rescheduling marijuana since the Food and Drug Administration (“FDA”) and Health and Human Services (“HHS”) recommended the Drug Enforcement Administration (“DEA”) reschedule from schedule I to schedule III last August. By Larry K.

Controlled Substances 59

Controlled Substances FDA 59

The Checkup by Singlecare

JULY 20, 2024

Food and Drug Administration ( FDA ) as a weight loss medication. It is a Schedule IV controlled substance and is sold under the brand names Adipex-P and Lomaira. As of now, phentermine is not FDA-approved for ADHD, and the evidence of its effectiveness is scarce. It does not have the approved indication for ADHD.”

Adverse Reactions 90

Adverse Reactions FDA Controlled Substances Documentation 90

Pharmaceutical Technology

MAY 9, 2023

In February, the FDA issued an alert restricting the import of the veterinary sedative xylazine or tranq and the ingredients used to make the drug. There have been calls to make xylazine a scheduled drug in the US, but so far only three states have classified it as a controlled substance. Fact box: What is tranq?

Controlled Substances 111

Controlled Substances FDA 111

The FDA Law Blog

NOVEMBER 29, 2022

Houck — On November 4th, CDC issued its revised guideline on prescribing opioids for pain as an expansion and update of its 2016 CDC Opioid Prescribing Guideline. We blogged on the 2016 guideline here in March 2016, and the proposed guideline here on March 18th). By Larry K. Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R.,

Patient Care 52

Patient Care Dosage Controlled Substances Insurance 52

The FDA Law Blog

APRIL 21, 2024

Post-AIA, and a later change to the law to account for controlled substance FDA application approvals, the PTE statute at 35 U.S.C. § Rather, “permission for commercial marketing” was only effective upon FDA’s issuance of its corrected October 5, 2022 letter. which brings us to the topic of this post. Patent Nos.

Labelling 59

Labelling FDA Controlled Substances 59

The Checkup by Singlecare

MAY 5, 2024

It occurs most often in children, and there have been an estimated 6 million children in the United States who have received a diagnosis as of 2016. It’s a Schedule II controlled substance that’s approved by the U.S. Food and Drug Administration (FDA) to treat ADHD. Treatments include behavioral therapy and medications.

Controlled Substances 52

Controlled Substances Labelling Insurance Dosage 52

The Checkup by Singlecare

DECEMBER 12, 2023

The Food and Drug Administration (FDA) even sent a special communication to call attention to this risk. The Drug Enforcement Administration (DEA) categorizes zolpidem as a controlled substance, meaning that it has significant potential for abuse. For that reason, it is typically best to avoid combining opiates with zolpidem.

Adverse Reactions 52

Adverse Reactions Controlled Substances Communication Labelling 52

The FDA Law Blog

MAY 21, 2024

Houck — Last August Health and Human Services (“HHS”) recommended rescheduling marijuana from schedule I under the federal Controlled Substances Act (“CSA”) to schedule III. 12, 2016) ; Denial of Petition to Initiate Proceedings to reschedule Marijuana, 81 Fed. 12, 2016). 53,688 (Aug. 53,767 (Aug. 21 U.S.C. §

Controlled Substances 69

Controlled Substances Chemotherapy FDA Dosage 69

The FDA Law Blog

SEPTEMBER 5, 2023

Houck — Scheduling Criteria Under the Controlled Substances Act (“CSA”) Schedule I: • High potential for abuse; • No currently accepted medical use in treatment in the U.S.; Schedule III: • Potential for abuse less than drugs or substances in schedules I and II; • Currently accepted medical use in treatment in the U.S.;

Controlled Substances 111

Controlled Substances FDA 111

The FDA Law Blog

MAY 5, 2024

Houck — The Associated Press reported on Tuesday following confirmation by five anonymous individuals with knowledge that the Drug Enforcement Administration (“DEA”) is moving to reschedule marijuana from schedule I to the less stringently controlled schedule III. Whether the drug is an immediate precursor of a substance already controlled.

Controlled Substances 95

Controlled Substances FDA Chemotherapy Dosage 95

The FDA Law Blog

DECEMBER 21, 2023

Director Larry Houck will present a webinar on HHS’ cannabis rescheduling recommendation hosted by the National Association of State Controlled Substance Authorities (“NASCSA”) scheduled for Tuesday, January 9, 2024 at 3:00 pm (Eastern). Hyman, Phelps & McNamara, P.C.,

Controlled Substances 52

Controlled Substances 52

The FDA Law Blog

FEBRUARY 11, 2024

There has been no evidence that marijuana’s schedule should change since the last rescheduling review in 2016. FDA has not approved marijuana for medical use because no double-blind, published studies show safety and efficacy for raw marijuana. In other words, no rescheduling.

Controlled Substances 59

Controlled Substances Chemotherapy FDA Compounding 59

The Thyroid Pharmacist

NOVEMBER 15, 2024

17] Ozempic is a once-weekly injection that was approved by the FDA in 2017 for use in adults with type 2 diabetes. I also prefer semaglutide drugs over other weight loss drugs out there (for example, phentermine, a controlled substance that can be habit forming, or orlistat, a drug that results in fat malabsorption and “disaster pants”).

Immunization 75

Immunization Compounding Compounding Pharmacies Labelling 75

The FDA Law Blog

JUNE 23, 2024

Palmer — For more than 50 years, the Drug Enforcement Administration (DEA) has enforced the central mandate of the Controlled Substances Act (CSA) to maintain a closed chain of distribution for drugs with a potential for abuse and diversion. 2] Why is this an issue? the “ultimate user”).

Controlled Substances 98

Controlled Substances Compounding Patient Care FDA 98